Position in URGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$81,699,232
-$24,718,788 QoQ
Shares Held
4,543,895
0.0% QoQ
Ownership
9.33%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in URGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RTW INVESTMENTS, LP holds $8,256,157,304 across 64 Biotechnology names. URGN ranks #25 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,993,687 | $1,043,635,333 | |
| 2 | INSM |
INSMED Inc
|
4,842,880 | $791,907,737 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
5,059,053 | $533,224,186 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
7,746,415 | $527,763,253 | |
| 5 | ARGX |
Argenx SE
|
709,446 | $518,072,941 | |
| 6 | CGON |
CG Oncology, Inc.
|
6,984,808 | $472,731,805 | |
| 7 | CELC |
Celcuity Inc.
|
3,039,621 | $346,942,340 | |
| 8 | TNGX |
Tango Therapeutics, Inc.
|
13,300,620 | $278,248,970 |
All Filings in URGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $81,699,232 | 4,543,895 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $106,418,020 | 4,543,895 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $90,650,705 | 4,543,895 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $62,251,361 | 4,543,895 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $42,412,821 | 3,834,794 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $40,840,556 | 3,834,794 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $48,099,306 | 3,787,347 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $59,692,282 | 3,557,347 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $48,860,205 | 3,257,347 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $25,902,120 | 1,726,808 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,013,070 | 857,464 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,874,752 | 857,464 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,922,967 | 857,464 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,605,705 | 857,464 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,134,100 | 857,464 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,022,630 | 857,464 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $7,468,511 | 857,464 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $8,154,482 | 857,464 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $14,422,544 | 857,464 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||